Pressure-induced Renal Injury in Angiotensin II Versus Norepinephrine-induced Hypertensive Rats
Overview
Affiliations
The susceptibility to renal perfusion pressure (RPP)-induced renal injury was investigated in angiotensin II (Ang II)- versus norepinephrine (NE)-infused hypertensive rats. To determine the magnitude of RPP-induced injury, Sprague-Dawley rats fed a 4% salt diet were instrumented with a servocontrolled aortic balloon occluder positioned between the renal arteries to maintain RPP to the left kidney at baseline levels whereas the right kidney was exposed to elevated RPP during a 2-week infusion of Ang II IV (25 ng/kg per minute), NE IV (0.5, 1.0, and 2.0 microg/kg per minute on days 1, 2, and 3 to 14, respectively), or saline IV (sham rats). Over the 14 days of Ang II infusion, RPP averaged 161.5+/-8.0 mm Hg to uncontrolled kidneys and 121.9+/-2.0 mm Hg to servocontrolled kidneys. In NE-infused rats, RPP averaged 156.3+/-3.0 mm Hg to uncontrolled kidneys and 116.9+/-2.0 mm Hg to servocontrolled kidneys. RPP averaged 111.1+/-1.0 mm Hg to kidneys of sham rats. Interlobular arterial injury and juxtamedullary glomerulosclerosis were largely RPP dependent in both models of hypertension. Superficial cortical glomerulosclerosis was greater and RPP dependent in NE- versus Ang II-infused rats, which was primarily independent of RPP. Outer medullary tubular necrosis and interstitial fibrosis were also primarily RPP dependent in both models of hypertension; however, the magnitude of injury was exacerbated in Ang II-infused rats. We conclude that elevated RPP is the dominant cause of renal injury in both NE- and Ang II-induced hypertensive rats and that underlying neurohumoral factors in these models of hypertension alter the pattern and magnitude of RPP-induced renal injury.
Chivers J, Whiles S, Miles C, Biederman B, Ellison M, Lovingood C Am J Physiol Renal Physiol. 2022; 324(2):F193-F210.
PMID: 36475869 PMC: 9886360. DOI: 10.1152/ajprenal.00145.2022.
Shimada S, Yang C, Kumar V, Mattson D, Cowley Jr A Hypertension. 2022; 79(6):1180-1189.
PMID: 35291809 PMC: 9098670. DOI: 10.1161/HYPERTENSIONAHA.121.18643.
Shimada S, Yang C, Kurth T, Cowley Jr A Am J Physiol Renal Physiol. 2022; 322(5):F473-F485.
PMID: 35224992 PMC: 8977133. DOI: 10.1152/ajprenal.00376.2021.
Gutsol A, Blanco P, Hale T, Thibodeau J, Holterman C, Nasrallah R PLoS One. 2022; 17(2):e0264136.
PMID: 35176122 PMC: 8853553. DOI: 10.1371/journal.pone.0264136.
Dhande I, Braun M, Doris P Hypertension. 2021; 78(6):1689-1700.
PMID: 34757770 PMC: 8577298. DOI: 10.1161/HYPERTENSIONAHA.121.18112.